BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30885698)

  • 1. Identification of new Wilms tumour predisposition genes: an exome sequencing study.
    Mahamdallie S; Yost S; Poyastro-Pearson E; Holt E; Zachariou A; Seal S; Elliott A; Clarke M; Warren-Perry M; Hanks S; Anderson J; Bomken S; Cole T; Farah R; Furtwaengler R; Glaser A; Grundy R; Hayden J; Lowis S; Millot F; Nicholson J; Ronghe M; Skeen J; Williams D; Yeomanson D; Ruark E; Rahman N
    Lancet Child Adolesc Health; 2019 May; 3(5):322-331. PubMed ID: 30885698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM28 haploinsufficiency predisposes to Wilms tumor.
    Diets IJ; Hoyer J; Ekici AB; Popp B; Hoogerbrugge N; van Reijmersdal SV; Bhaskaran R; Hadjihannas M; Vasileiou G; Thiel CT; Seven D; Uebe S; Ilencikova D; Waanders E; Mavinkurve-Groothuis AMC; Roeleveld N; de Krijger RR; Wegert J; Graf N; Vokuhl C; Agaimy A; Gessler M; Reis A; Kuiper RP; Jongmans MCJ; Metzler M
    Int J Cancer; 2019 Aug; 145(4):941-951. PubMed ID: 30694527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline mutations and somatic inactivation of TRIM28 in Wilms tumour.
    Halliday BJ; Fukuzawa R; Markie DM; Grundy RG; Ludgate JL; Black MA; Skeen JE; Weeks RJ; Catchpoole DR; Roberts AGK; Reeve AE; Morison IM
    PLoS Genet; 2018 Jun; 14(6):e1007399. PubMed ID: 29912901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM28 variants and Wilms' tumour predisposition.
    Hol JA; Diets IJ; de Krijger RR; van den Heuvel-Eibrink MM; Jongmans MC; Kuiper RP
    J Pathol; 2021 Jul; 254(4):494-504. PubMed ID: 33565090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms tumour resulting from paternal transmission of a TRIM28 pathogenic variant-A first report.
    Whitworth J; Armstrong R; Maher ER
    Eur J Hum Genet; 2024 Mar; 32(3):361-364. PubMed ID: 38282073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene.
    Slade I; Stephens P; Douglas J; Barker K; Stebbings L; Abbaszadeh F; Pritchard-Jones K; ; Cole R; Pizer B; Stiller C; Vujanic G; Scott RH; Stratton MR; Rahman N
    J Med Genet; 2010 May; 47(5):342-7. PubMed ID: 19948536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evidence that the neurodevelopmental gene FBXW7 predisposes to Wilms tumor.
    Meier-Abt F; Kraemer D; Braun N; Reinehr M; Stutz-Grunder E; Steindl K; Rauch A
    Am J Med Genet A; 2024 Jun; 194(6):e63528. PubMed ID: 38169111
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Moore C; Monforte H; Teer JK; Zhang Y; Yoder S; Brohl AS; Reed DR
    Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32699065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM28 inactivation in epithelial nephroblastoma is frequent and often associated with predisposing TRIM28 germline variants.
    Wegert J; Fischer AK; Palhazi B; Treger TD; Hilgers C; Ziegler B; Jung H; Jüttner E; Waha A; Fuchs J; Warmann SW; Frühwald MC; Hubertus J; Pritchard-Jones K; Graf N; Behjati S; Furtwängler R; Gessler M; Vokuhl C
    J Pathol; 2024 Jan; 262(1):10-21. PubMed ID: 37792584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients.
    Segers H; Kersseboom R; Alders M; Pieters R; Wagner A; van den Heuvel-Eibrink MM
    Eur J Cancer; 2012 Nov; 48(17):3249-56. PubMed ID: 22796116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
    Rahman N; Arbour L; Tonin P; Baruchel S; Pritchard-Jones K; Narod SA; Stratton MR
    Oncogene; 1997 Jun; 14(25):3099-102. PubMed ID: 9223674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.
    Williams RD; Al-Saadi R; Chagtai T; Popov S; Messahel B; Sebire N; Gessler M; Wegert J; Graf N; Leuschner I; Hubank M; Jones C; Vujanic G; Pritchard-Jones K; ;
    Clin Cancer Res; 2010 Apr; 16(7):2036-45. PubMed ID: 20332316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour.
    Palculict TB; Ruteshouser EC; Fan Y; Wang W; Strong L; Huff V
    J Med Genet; 2016 Jun; 53(6):385-8. PubMed ID: 26566882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour.
    Hanks S; Perdeaux ER; Seal S; Ruark E; Mahamdallie SS; Murray A; Ramsay E; Del Vecchio Duarte S; Zachariou A; de Souza B; Warren-Perry M; Elliott A; Davidson A; Price H; Stiller C; Pritchard-Jones K; Rahman N
    Nat Commun; 2014 Aug; 5():4398. PubMed ID: 25099282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the transcriptional repressor REST predispose to Wilms tumor.
    Mahamdallie SS; Hanks S; Karlin KL; Zachariou A; Perdeaux ER; Ruark E; Shaw CA; Renwick A; Ramsay E; Yost S; Elliott A; Birch J; Capra M; Gray J; Hale J; Kingston J; Levitt G; McLean T; Sheridan E; Renwick A; Seal S; Stiller C; Sebire N; Westbrook TF; Rahman N
    Nat Genet; 2015 Dec; 47(12):1471-4. PubMed ID: 26551668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma.
    Abbaszadeh F; Barker KT; McConville C; Scott RH; Rahman N
    Fam Cancer; 2010 Sep; 9(3):425-30. PubMed ID: 20054657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo and Inherited Pathogenic Variants in KDM3B Cause Intellectual Disability, Short Stature, and Facial Dysmorphism.
    Diets IJ; van der Donk R; Baltrunaite K; Waanders E; Reijnders MRF; Dingemans AJM; Pfundt R; Vulto-van Silfhout AT; Wiel L; Gilissen C; Thevenon J; Perrin L; Afenjar A; Nava C; Keren B; Bartz S; Peri B; Beunders G; Verbeek N; van Gassen K; Thiffault I; Cadieux-Dion M; Huerta-Saenz L; Wagner M; Konstantopoulou V; Vodopiutz J; Griese M; Boel A; Callewaert B; Brunner HG; Kleefstra T; Hoogerbrugge N; de Vries BBA; Hwa V; Dauber A; Hehir-Kwa JY; Kuiper RP; Jongmans MCJ
    Am J Hum Genet; 2019 Apr; 104(4):758-766. PubMed ID: 30929739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children's Oncology Group study.
    Armstrong AE; Gadd S; Huff V; Gerhard DS; Dome JS; Perlman EJ
    PLoS One; 2018; 13(12):e0208936. PubMed ID: 30543698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial rhabdoid tumour 'avant la lettre'--from pathology review to exome sequencing and back again.
    Witkowski L; Lalonde E; Zhang J; Albrecht S; Hamel N; Cavallone L; May ST; Nicholson JC; Coleman N; Murray MJ; Tauber PF; Huntsman DG; Schönberger S; Yandell D; Hasselblatt M; Tischkowitz MD; Majewski J; Foulkes WD
    J Pathol; 2013 Sep; 231(1):35-43. PubMed ID: 23775540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort.
    Stoltze UK; Hildonen M; Hansen TVO; Foss-Skiftesvik J; Byrjalsen A; Lundsgaard M; Pignata L; Grønskov K; Tumer Z; Schmiegelow K; Brok JS; Wadt KAW
    J Med Genet; 2023 Sep; 60(9):842-849. PubMed ID: 37019617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.